1. Home
  2. CCNE vs ARVN Comparison

CCNE vs ARVN Comparison

Compare CCNE & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$26.88

Market Cap

736.3M

Sector

Finance

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$12.53

Market Cap

740.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCNE
ARVN
Founded
1865
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
736.3M
740.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CCNE
ARVN
Price
$26.88
$12.53
Analyst Decision
Hold
Buy
Analyst Count
1
23
Target Price
$29.00
$17.80
AVG Volume (30 Days)
101.9K
2.6M
Earning Date
10-30-2025
11-05-2025
Dividend Yield
2.67%
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$227,923,000.00
$312,300,000.00
Revenue This Year
$13.84
N/A
Revenue Next Year
$27.68
N/A
P/E Ratio
$14.11
N/A
Revenue Growth
5.27
93.86
52 Week Low
$19.32
$5.90
52 Week High
$28.30
$26.78

Technical Indicators

Market Signals
Indicator
CCNE
ARVN
Relative Strength Index (RSI) 69.72 62.14
Support Level $25.78 $11.66
Resistance Level $26.20 $12.62
Average True Range (ATR) 0.63 0.90
MACD 0.21 0.04
Stochastic Oscillator 89.88 61.61

Price Performance

Historical Comparison
CCNE
ARVN

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: